Thisstudywasaimedatcomparingadolescentandyoungadult(AYA)Hematopoietic Stem Cell Transplantation (HSCT) paediatric cancer survivors and a control group of healthy peers in terms of Health- Related Quality of Life (HRQOL) and frequency of posttraumaticstresssymptoms(PTSS).Theparticipantswere32AYAHSCTsurvi- vors and 28 matched healthy peers. The survivors were, on average, 19.4 years old (SD = 3.8), with an average age of 8.1 years (SD = 4.3) at diagnosis, and with a mean time, since treatment was completed, of 8.5 years (SD = 3.2). The majority of survi- vors (78.1%) did not show clinical PTSS, with intrusion symptoms most frequently reported in those who had undergone autologous HSCT (F = 3.3; df = 2; p = 0.05) and relapse presence in their treatment associated with more PTSS avoidance symptoms (r = 0.4; p=0.002).WomenreportedmoreproblemsintheSF-36painscale(t = 2.1; df = 31; p=0.04)thanmen.Additionally,87.5%ofsurvivorsfellbelowthe25thper- centileintheSF-36generalwell-beingscale,and70.8%hadthesametrendforthe SF-36fatiguescale.Survivorsreportedbetteremotionalwell-being(t=2.6,df = 27, p = 0.01) and fewer limitations than their healthy peers (t = 2.5, df = 27, p = 0.02), while they perceived a lower life satisfaction referring to the past (t=−2.8,df = 27, p = 0.009).

Health-related quality of life in AYA cancer survivors who underwent HSCT compared with healthy peers

Tremolada M.
;
Bonichini S.;Basso G.;
2018

Abstract

Thisstudywasaimedatcomparingadolescentandyoungadult(AYA)Hematopoietic Stem Cell Transplantation (HSCT) paediatric cancer survivors and a control group of healthy peers in terms of Health- Related Quality of Life (HRQOL) and frequency of posttraumaticstresssymptoms(PTSS).Theparticipantswere32AYAHSCTsurvi- vors and 28 matched healthy peers. The survivors were, on average, 19.4 years old (SD = 3.8), with an average age of 8.1 years (SD = 4.3) at diagnosis, and with a mean time, since treatment was completed, of 8.5 years (SD = 3.2). The majority of survi- vors (78.1%) did not show clinical PTSS, with intrusion symptoms most frequently reported in those who had undergone autologous HSCT (F = 3.3; df = 2; p = 0.05) and relapse presence in their treatment associated with more PTSS avoidance symptoms (r = 0.4; p=0.002).WomenreportedmoreproblemsintheSF-36painscale(t = 2.1; df = 31; p=0.04)thanmen.Additionally,87.5%ofsurvivorsfellbelowthe25thper- centileintheSF-36generalwell-beingscale,and70.8%hadthesametrendforthe SF-36fatiguescale.Survivorsreportedbetteremotionalwell-being(t=2.6,df = 27, p = 0.01) and fewer limitations than their healthy peers (t = 2.5, df = 27, p = 0.02), while they perceived a lower life satisfaction referring to the past (t=−2.8,df = 27, p = 0.009).
File in questo prodotto:
File Dimensione Formato  
Tremolada_et_al-2018-European_Journal_of_Cancer_Care.pdf

accesso aperto

Tipologia: Published (publisher's version)
Licenza: Creative commons
Dimensione 466.39 kB
Formato Adobe PDF
466.39 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3294426
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 29
social impact